Recent Updates
Recently added Catalysts
HRMY Negative Sentiment Score: 25/100

Harmony Biosciences Holdings: Company Investigated by the Portnoy Law Firm

Key Takeaway: Harmony Biosciences Holdings, Inc. is currently under investigation by the Portnoy Law Firm for possible securities fraud, following a report by Scorpion Capital. The report alleges that there were fatalities during clinical trials of the company's drug Wakix and that essential information was concealed from the FDA. This has led to a decrease in the company's share value. Investors who suffered losses are encouraged to contact the law firm for assistance in recovering their investments.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investigation into possible securities fraud could negatively impact investor confidence.
  • Report by Scorpion Capital alleges fatalities during clinical trials of Wakix.
  • Claims of concealment of information from the FDA may lead to regulatory repercussions.
  • Company's share value experienced a decline following the allegations.

Full Press Release Details

Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, March 29, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Harmony Biosciences Holdings, Inc. (“Harmony Biosciences” or the “Company”) (NASDAQ: HRMY) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Harmony Biosciences investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On the 28th of March 2023, Scorpion Capital made public a report that asserts that a dozen fatalities took place during the foreign clinical trials of the drug Wakix. In addition, Scorpion Capital claims that the concealment of crucial information from the FDA would have hindered the approval of Wakix. As a result of this report, the value of the Company's shares experienced a decline.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising

Tags

Frequently Asked Questions

How can investors contact the Portnoy Law Firm?

Investors can reach out to the law firm by phone at 844-767-8529 or via email at lesley@portnoylaw.com.

What is the investigation about Harmony Biosciences?

The Portnoy Law Firm is investigating potential securities fraud related to Harmony Biosciences.

What prompted the investigation into Harmony Biosciences?

A report from Scorpion Capital alleged fatalities during Wakix trials and information concealment.

Is there a cost for the case evaluation from the law firm?

No, the Portnoy Law Firm offers a complimentary case evaluation for investors.

What can investors do to recover their losses?

Investors can contact the Portnoy Law Firm to explore options for pursuing claims.

Last updated: Mar 30, 2023